Inhibition of CEBPB Attenuates Lupus Nephritis via Regulating Pim-1 Signaling

Systemic lupus erythematosus (SLE) is an autoimmune disease leading to inflammatory damage in multiple target organs, and lupus nephritis (LN) is one of the most life-threatening organ manifestations. CCAAT/enhancer-binding protein β (CEBPB) regulates the NLRP3 inflammasome and is involved in the pa...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaoyang Wang (Author), Weili Cheng (Author), Xiaopan Chen (Author), Yanan Gong (Author), Guangjie Wang (Author), Xiaoxue Zhang (Author), Yuanyuan Qi (Author)
Format: Book
Published: Hindawi Limited, 2022-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_1e8c8c032fbc4a39aca51cf9f66b3ba9
042 |a dc 
100 1 0 |a Xiaoyang Wang  |e author 
700 1 0 |a Weili Cheng  |e author 
700 1 0 |a Xiaopan Chen  |e author 
700 1 0 |a Yanan Gong  |e author 
700 1 0 |a Guangjie Wang  |e author 
700 1 0 |a Xiaoxue Zhang  |e author 
700 1 0 |a Yuanyuan Qi  |e author 
245 0 0 |a Inhibition of CEBPB Attenuates Lupus Nephritis via Regulating Pim-1 Signaling 
260 |b Hindawi Limited,   |c 2022-01-01T00:00:00Z. 
500 |a 1466-1861 
500 |a 10.1155/2022/2298865 
520 |a Systemic lupus erythematosus (SLE) is an autoimmune disease leading to inflammatory damage in multiple target organs, and lupus nephritis (LN) is one of the most life-threatening organ manifestations. CCAAT/enhancer-binding protein β (CEBPB) regulates the NLRP3 inflammasome and is involved in the pathogenesis of SLE. However, the role and mechanism of CEBPB in LN remains unclear. MRL/lpr mice and lipopolysaccharides (LPS) combined with adenosine triphosphate- (ATP-) treated glomerular podocytes were used as models of LN in vivo and in vitro, respectively. In vivo, we investigated the expressions of CEBPB during the development of MRL/lpr mice. Then we assessed the effect of CEBPB inhibition on renal structure and function through injecting shCEBPB lentivirus into MRL/lpr mice. In vitro, glomerular podocytes were treated with Pim-1-OE and siCEBPB to explore the relation between CEBPB and Pim-1. The progression of LN in mice was associated with the increased level of CEBPB, and the inhibition of CEBPB ameliorated renal structure impairments and improved renal function damage associated with LN. Knockdown of CEBPB could suppress the activation of NLRP3 inflammasome and the secretion of IL-1β and IL-6. Furthermore, the knockdown of CEBPB could inhibit NLRP3 inflammasome activation and pyroptosis via binding to Pim-1 promoter to downregulate its expression, and the overexpression of Pim-1 reversed the effects of CEBPB deficiency. The regulation of CEBPB on Pim-1 facilitated pyroptosis by activating NLRP3 inflammasome, thereby promoting the development of LN. 
546 |a EN 
690 |a Pathology 
690 |a RB1-214 
655 7 |a article  |2 local 
786 0 |n Mediators of Inflammation, Vol 2022 (2022) 
787 0 |n http://dx.doi.org/10.1155/2022/2298865 
787 0 |n https://doaj.org/toc/1466-1861 
856 4 1 |u https://doaj.org/article/1e8c8c032fbc4a39aca51cf9f66b3ba9  |z Connect to this object online.